Breaking ground in the pharmaceutical industry published by Novartis, Digital magazine iMag focuses on the disease of psoriasis and urticarial. A tablet application, NovartisiMag provides comprehensive and detailed information about new subjects wondered and diseases in its every issues. Supported by visual and video, NovartisiMag consists of news from Novartis, educational articles, travel notes, recipes and information about activities in the city. Novartis has five business segments and is supported by our global research organization, the Novartis Institutes for BioMedical Research (NIBR). These segments are strategically aligned to bring innovative, high-quality and affordable medicines and therapies to patients around the world. Making full use of its cross-divisional cooperation potential, Novartis continually looks for opportunities to leverage the strength of its global and diverse businesses to meet patient needs and extend its differentiated leadership position. We continuously evolve our businesses to create a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Pharmaceuticals develops innovative, patentprotected medicines to enhance health outcomes for patients and health-care providers. The division is at the forefront of development and commercialization in oncology, primary care and specialty medicines. Android users can access the journal via Google Play Store.